Anti-Platelet Drug Resistance in the Prediction of Thromboembolic Complications after Neurointervention
![]() ![]() |
Ryu, Dal-Sung
(Department of Neurosurgery, Cerebrovascular Center, Gangnam Severance Hospital, Yonsei University College of Medicine)
Hong, Chang-Ki (Department of Neurosurgery, Cerebrovascular Center, Gangnam Severance Hospital, Yonsei University College of Medicine) Sim, Yoo-Sik (Department of Neurosurgery, Cerebrovascular Center, Gangnam Severance Hospital, Yonsei University College of Medicine) Kim, Chang-Hyun (Department of Neurosurgery, Cerebrovascular Center, Gangnam Severance Hospital, Yonsei University College of Medicine) Jung, Jin-Young (Department of Neurosurgery, Cerebrovascular Center, Gangnam Severance Hospital, Yonsei University College of Medicine) Joo, Jin-Yang (Department of Neurosurgery, Cerebrovascular Center, Gangnam Severance Hospital, Yonsei University College of Medicine) |
1 | Lee DH, Arat A, Morsi H, Shaltoni H, Harris JR, Mawad ME : Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience. AJNR Am J Neuroradiol 29 : 1389-1394, 2008 DOI ScienceOn |
2 | Patrono C, Bachmann F, Baigent C, Bode C, De Caterina R, Charbonnier B, et al. : Expert consensus document on the use of antiplatelet agents. The task: force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J 25: 166-181, 2004 DOI ScienceOn |
3 | Szczeklik A, Musial J, Undas A, Gajewski P, Gora P, Swadzba J, et al. : Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypetcholesterolemia. J Am Coll Cardiol 33 : 1286-1293, 1999 DOI |
4 | Weksler BB, Lewin M ; Antieoagulation in cerebral ischemia. Stroke 14: 658-663,1983 DOI ScienceOn |
5 | Li Y, Woo V, Bose R : Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus. Am J Physiol Heart Cire Physiol 280 : H1480-1489,2001 DOI |
6 | Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, et al. : Effects of pretreatment with clopidogrel and aspirin followed by long-term rherapy in patients undergoing percutaneous coronary intervention : the PCI-CURE study. Lancet 358 : 527-533, 2001 DOI |
7 | Motovska Z, Widimsky P, Petr R, Bilkova D, Marinov I, Simek S, et al. : Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing e1eetive percutaneous coronary intervention : statin's advantage and rhe smoking "paradox". J Cardiovasc Pharmacol 53 : 368-372, 2009 DOI ScienceOn |
8 | Oqueli E, Hiscock M, Dick R : Clopidogrel resistance. Heart Lung Circ 16 Suppl 3 : S17-S28, 2007 |
9 | Gurbel PA, Tantry US : Clopidogrel resistance? Thromb Res 120 : 311-321,2007 DOI ScienceOn |
10 | Gurbel PA, Bliden KP, Hayes KM, Yoho JA, Herzog WR, Tantry US: The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. J Am Coll Cardiol 45 : 1392-1396,2005 DOI ScienceOn |
11 | Yusuf S, Zhao F, Metha SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345: 494-502, 2001 DOI ScienceOn |
12 | Albers GW : Antithrombotic agents in cerebral ischemia. Am J Cardiol 75: 34B-38B, 1995 DOI ScienceOn |
13 | Grau AJ, Reiners S, Lichy C, Buggie F, Ruf A : Platelet funetion under aspirin, clopidogrel, and borh after ischemic stroke : a case-crossover study. Stroke 34 : 849-854, 2003 DOI |
14 | Coma-Canella I, Valasc A : Vatiability in individual responsiveness to aspirin : clinical implications and treatment. Cardiovasc Haematol Disord Drug Targets 7: 274-287,2007 DOI ScienceOn |
15 | Fitzgerald DJ, Maree A: Aspirin and clopidogrel resistance. Hematology Am Soc Hematol Edue Program: 114-120, 2007 |
16 | Davi G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, et al. : Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease pet se are associated with persistent platelet aetivation in vivo. Evidence derived from the study of peripheral arterial disease. Circulation 96: 69-75, 1997 DOI ScienceOn |
17 | Ferreira IA, Mocking AI, Feijge MA, Gorter G, van Haeften TW, Heemskerk JW, et al. : Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vase Biol 26 : 417-422, 2006 |
18 | Cattaneo M: Laboratory detection of 'aspirin resistance': what test should we use (if any)? Eur Heart J 28:1673-1675, 2007 DOI ScienceOn |
19 | Csiszar A., Stef G, Pacher P, Ungvari Z : Oxidative stress-induced isoprostane formation may contribute to aspirin resistance in platelets. Prostaglandins Leukot Essent Fatty Acids 66: 557-558, 2002 DOI ScienceOn |
20 | Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. : Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357: 2001-2015, 2007 DOI ScienceOn |
21 | Wang TH, Bhatt DL, Topol EJ : Aspirin and clopidogrel resistance : an emerging clinical entity. Eur Heart J 27 : 647-654, 2006 DOI ScienceOn |
22 | Dalen JE : Aspirin resistance: is it real? Is it clinically significant? Am J Med 120 : 1-4, 2007 DOI ScienceOn |
23 | Winocour PD, Watala C, Perry DW, Kinlough-Rathbone RL : Decreased platelet membrane fluidity due to glycation or acetylation of membrane proteins. Thromb Haemost 68: 577-582, 1992 |
24 | Wiviott SD : Clopidogrel response variability, resistance, or both? Am J Cardiol 98: 18N-24N, 2006 |
25 | Shim CY, Yoon SJ, Park S, Kim JS, Choi JR, Ko YG, et al.: The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation. Int J Cardiol 134 : 351-355,2009 DOI ScienceOn |
26 | Steinhubl SR, Berger PB, Mann JT 3rd. Fty ET, DeLago A, Wilmer C, et al. : Early and sustained dual oral antiplarelet therapy following percutaneous coronary intervention : a randomized controlled trial. JAMA 288: 2411-2420, 2002 DOI ScienceOn |
27 | Tschoepe D, Roesen P, Esser J, Schwippert B, Nieuwenhuis HK, Kehrel B, et al. : Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 17 : 433-438, 1991 DOI |
28 | von Beckerarh N. Kastrati A, Wieczorek A, Pogatsa-Murray G, Sibbing D, Graf I, et al. : A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days. Eur Heart J 28 : 1814-1819, 2007 DOI ScienceOn |
29 | Prabhakaran S, Wells KR, Lee VH, Flaherty CA, Lopes DK: Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting. AJNR Am J Neuroradiol 29: 281-285, 2008 DOI ScienceOn |
30 | Cairns JA, Eikelboom J : Clopidogrel resistance: more grist for the mill. J Am Coll Cardiol 51: 1935-1937,2008 DOI ScienceOn |
31 | Rothrock JF, Hart RG : Antithrombotic therapy in cerebrovascular disease. Ann Intern Med 115 : 885-895, 1991 DOI ScienceOn |
32 | Saratzis A, Saratzis N, Melas N, Kiskinis D : Pharmaeorherapy before and after endovascular repair of abdominal aortic aneurysms. Curr Vasc Pharmacol 6 : 240-249, 2008 DOI ScienceOn |
33 | Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Sabate M, Jimenez-Quevedo P, et al. : Platelet function profiles in patients wich type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes 54: 2430-2435, 2005 DOI ScienceOn |
34 | Lee SW, Park SW, Hong MK, Kim YH, Lee BK, Song JM, et aI. : Triple versus dual antiplatelet therapy after coronary stenting : impac.t on stent thrombosis. J Am Coll Cardiol 46 : 1833-1837. 2005 DOI ScienceOn |
35 | Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, Delao T, et al. : Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention : the role of dual drug resistance. J Am Coil Cardiol 47 : 27-33, 2006 DOI ScienceOn |
![]() |